BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/20/2024 8:03:28 AM | Browse: 51 | Download: 223
Publication Name World Journal of Transplantation
Manuscript ID 98155
Country United Kingdom
Received
2024-06-19 05:00
Peer-Review Started
2024-06-19 05:00
To Make the First Decision
Return for Revision
2024-07-05 02:14
Revised
2024-07-18 01:01
Second Decision
2024-07-24 02:36
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2024-07-24 08:17
Articles in Press
2024-07-24 08:17
Publication Fee Transferred
2024-09-02 06:30
Edit the Manuscript by Language Editor
Typeset the Manuscript
2024-09-09 03:37
Publish the Manuscript Online
2024-09-20 08:03
ISSN 2220-3230 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Urology & Nephrology
Manuscript Type Systematic Reviews
Article Title Review of plasma exchange and rituximab for prevention of recurrent focal segmental glomerulosclerosis after a prior graft loss
Manuscript Source Unsolicited Manuscript
All Author List Sophie Gharaei, Hashim Abbas and Durga Anil Kanigicherla
ORCID
Author(s) ORCID Number
Sophie Gharaei http://orcid.org/0000-0002-1122-1293
Durga Anil Kanigicherla http://orcid.org/0000-0003-3011-7878
Funding Agency and Grant Number
Corresponding Author Durga Anil Kanigicherla, MD, Doctor, Doctor, Department of Renal Medicine, Manchester University NHS Foundation Trust, Oxford Road, Manchester M13 9WL, United Kingdom. durga.kanigicherla@mft.nhs.uk
Key Words Focal Segmental Glomerulosclerosis; Glomerular Disease; Plasma Exchange; Rituximab; Transplantation
Core Tip Patients with prior graft losses due to post-transplant recurrence of focal segmental glomerulosclerosis (FSGS) are at particularly high risk of re-recurrence in subsequent transplants. With scarcity of transplants and limited options, prevention becomes vital. However, there has been a recommendation against the use of pre-emptive measures to prevent recurrence. Currently, there is too little evidence described in the literature to draw clear conclusions on the efficacy of preventative treatment. This lack of evidence for benefit does not necessarily equate to evidence of lack of benefit. Larger controlled studies are needed to investigate the effectiveness of pre-emptive measures.
Publish Date 2024-09-20 08:03
Citation <p>Gharaei S, Abbas H, Kanigicherla DA. Review of plasma exchange and rituximab for prevention of recurrent focal segmental glomerulosclerosis after a prior graft loss. <i>World J Transplant</i> 2024; 14(4): 98155</p>
URL https://www.wjgnet.com/2220-3230/full/v14/i4/98155.htm
DOI https://dx.doi.org/10.5500/wjt.v14.i4.98155
Full Article (PDF) WJT-14-98155-with-cover.pdf
PRISMA 2009 Checklist 98155-PRISMA-2009-Checklist.pdf
Manuscript File 98155_Auto_Edited_005114.docx
Answering Reviewers 98155-answering-reviewers.pdf
Audio Core Tip 98155-audio.mp3
Conflict-of-Interest Disclosure Form 98155-conflict-of-interest-statement.pdf
Copyright License Agreement 98155-copyright-assignment.pdf
Peer-review Report 98155-peer-reviews.pdf
Scientific Misconduct Check 98155-scientific-misconduct-check.png
Scientific Editor Work List 98155-scientific-editor-work-list.pdf
CrossCheck Report 98155-crosscheck-report.pdf
CrossCheck Report 98155-crosscheck-report.png